标题
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
作者
关键词
Myeloma, 3D-models, Natural killer, Micro-RNAs, Trabectedin
出版物
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-03-21
DOI
10.1186/s13045-019-0714-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-mir-17-92
- (2018) Eugenio Morelli et al. BLOOD
- miR-22 suppresses DNA ligase III addiction in multiple myeloma
- (2018) Daniele Caracciolo et al. LEUKEMIA
- The potential role of miRNAs in multiple myeloma therapy
- (2018) Daniele Caracciolo et al. Expert Review of Hematology
- Regulation of E2F1 Transcription Factor by Ubiquitin Conjugation
- (2017) Laurence Dubrez INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
- (2017) C Botta et al. LEUKEMIA
- Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer
- (2017) Jiaying Shen et al. Cell Death & Disease
- An E2F1/MiR-17-92 Negative Feedback Loop mediates proliferation of Mouse Palatal Mesenchymal Cells
- (2017) Ling Li et al. Scientific Reports
- Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
- (2017) Alessandra Zingoni et al. Frontiers in Immunology
- DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
- (2016) M. Gkotzamanidou et al. BLOOD
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
- (2016) Maria Pia Abruzzese et al. Journal of Hematology & Oncology
- Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
- (2016) Nicola Amodio et al. MOLECULAR CANCER THERAPEUTICS
- microRNAs with AAGUGC seed motif constitute an integral part of an oncogenic signaling network
- (2016) Y Zhou et al. ONCOGENE
- A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
- (2016) C Botta et al. Blood Cancer Journal
- A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
- (2015) A. Gulla et al. CLINICAL CANCER RESEARCH
- Transcription factor IKZF1 is degraded during the apoptosis of multiple myeloma cells induced by kinase inhibition
- (2015) Yaobin Liu et al. FEBS LETTERS
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells
- (2015) T Y Prudnikova et al. ONCOGENE
- The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies
- (2015) T Dosani et al. Blood Cancer Journal
- The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma
- (2015) Cinzia Fionda et al. Oncotarget
- A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
- (2015) Alboukadel Kassambara et al. Oncotarget
- CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma
- (2014) M. E. Murray et al. BLOOD
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
- (2014) H Yang et al. BRITISH JOURNAL OF CANCER
- Reactive Oxygen Species– and DNA Damage Response–Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1
- (2014) Alessandra Soriani et al. JOURNAL OF IMMUNOLOGY
- Automated Quantification Reveals Hyperglycemia Inhibits Endothelial Angiogenic Function
- (2014) Anthony R. Prisco et al. PLoS One
- The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells
- (2014) Cristina Cerboni et al. Frontiers in Immunology
- CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data
- (2013) Gabriela Bindea et al. BIOINFORMATICS
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- DNA repair pathways in human multiple myeloma
- (2013) Claire Gourzones-Dmitriev et al. CELL CYCLE
- Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy
- (2013) A. C. Chan et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immunologic microenvironment and personalized treatment in multiple myeloma
- (2013) Marco Rossi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Trabectedin mechanism of action: what’s new?
- (2013) Maurizio D’Incalci Future Oncology
- Analysis of DNA Repair-Related Genes in Breast Cancer Reveals CUL4A Ubiquitin Ligase as a Novel Biomarker of Trabectedin Response
- (2013) M. J. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- A diverse induction of apoptosis by trabectedin in MCF-7 (HER2−/ER+) and MDA-MB-453 (HER2+/ER−) breast cancer cells
- (2013) Harika Atmaca et al. TOXICOLOGY LETTERS
- The MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease
- (2012) Carla P. Concepcion et al. CANCER JOURNAL
- The role of natural killer cells in immunity against multiple myeloma
- (2012) James Godfrey et al. LEUKEMIA & LYMPHOMA
- MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma
- (2012) Xiao Gao et al. LEUKEMIA RESEARCH
- A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma
- (2012) Sarah Uboldi et al. PLoS One
- miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma
- (2011) Lijuan Chen et al. CANCER LETTERS
- Transcriptional and Nontranscriptional Functions of E2F1 in Response to DNA Damage
- (2011) A. K. Biswas et al. CANCER RESEARCH
- XPF-Dependent DNA Breaks and RNA Polymerase II Arrest Induced by Antitumor DNA Interstrand Crosslinking-Mimetic Alkaloids
- (2011) Sascha Feuerhahn et al. CHEMISTRY & BIOLOGY
- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
- (2009) Y. Zheng et al. BLOOD
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search